RecruitingNot ApplicableNCT07395635

Phase II Trial of Immunonutrition in Hepatectomy

Impact of Immunonutrition in Patients Undergoing Hepatectomies for Liver Tumors: A Randomized Controlled Phase II Trial


Sponsor

Tata Memorial Centre

Enrollment

100 participants

Start Date

Oct 3, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

A randomised open labelled study to evalaute the impact of immunonutrition in Patients Undergoing Hepatectomies for Liver Tumors


Eligibility

Min Age: 18 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This study is looking at whether a special pre-surgery diet called immunonutrition — which includes nutrients like arginine and fish oil — can improve recovery for patients having a major liver surgery to remove tumors. Researchers want to know if eating this diet before the operation leads to better outcomes. **You may be eligible if...** - You are 18 or older - You have a liver tumor and are scheduled for a major liver resection (removal of 3 or more liver sections) - Your overall health is classified as ASA Class 1, 2, or 3 **You may NOT be eligible if...** - You have severe kidney failure (low kidney filtration rate) - You have a known allergy to arginine, omega-3 fatty acids, or nucleotides - You are unable to eat by mouth Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTImmunonutrition

In addition to their usual intake, patients in the intervention arm will be prescribed for each of the 7 consecutive days preceding surgery 6-9 scoops PENTASURE Immunomax® powder (120-180g per day)


Locations(1)

Dr. Shraddha Patkar

Mumbai, Maharashtra, India

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07395635


Related Trials